<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0"><channel><title>BioMimetic Therapeutics RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehen</description><link>http://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><image><url>http://images.finanzen.net/images/finanzen_net_neu.gif</url><title>Finanzen.net</title><link>http://www.finanzen.net</link></image><item><title>BioMimetic Therapeutics Reports 2009 Fourth Quarter and Year End Earnings Results</title><link>http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Reports-2009-Fourth-Quarter-and-Year-End-Earnings-Results-756255</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwcellpaddingbottom1 {padding-bottom: 2.0px}
.bwcellpaddingbottom3 {padding-bottom: 4.0px}
.bwcellpaddingleft0 {padding-left: 0.0px}
.bwcellpaddingleft2 {padding-left: 10.0px}
.bwcellpaddingleft3 {padding-left: 15.0px}
.bwcellpaddingleft4  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Reports-2009-Fourth-Quarter-and-Year-End-Earnings-Results-756255</guid></item><item><title>BioMimetic Therapeutics Presents Promising Pre-Clinical Sports Medicine Data at the 2010 ORS Meeting</title><link>http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Presents-Promising-Pre-Clinical-Sports-Medicine-Data-at-the-2010-ORS-Meeting-754492</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
.bwunderlinestyle {text-decoration: underline}
--&gt;
&lt;/style&gt;

			&lt;!-- sh_cad_1 --&gt;
      BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced pre-clinical data 
      the Company  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Presents-Promising-Pre-Clinical-Sports-Medicine-Data-at-the-2010-ORS-Meeting-754492</guid></item><item><title>BioMimetic Therapeutics to Report 2009 Fourth Quarter and Year-End Financial Results on March 11</title><link>http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-to-Report-2009-Fourth-Quarter-and-Year-End-Financial-Results-on-March-11-754005</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
.bwunderlinestyle {text-decoration: underline}
--&gt;
&lt;/style&gt;

			&lt;!-- sh_cad_1 --&gt;
      BioMimetic Therapeutics, Inc. (NASDAQ:BMTI) today announced that the 
      Company plans  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-to-Report-2009-Fourth-Quarter-and-Year-End-Financial-Results-on-March-11-754005</guid></item><item><title>BioMimetic Therapeutics, Inc. to Highlight Pre-Clinical and Clinical Activities at ORS and AAOS Meetings</title><link>http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Inc-to-Highlight-Pre-Clinical-and-Clinical-Activities-at-ORS-and-AAOS-Meetings-752425</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwlistitemmarginbottom {margin-bottom: 10.0px}
.bwtextaligncenter {text-align: center}
.bwunderlinestyle {text-decoration: underline}
--&gt;
&lt;/style&gt;

			&lt;!-- sh_cad_1 --&gt;
      BioMimetic Therapeutics, Inc. (NASDAQ: BMTI)  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Inc-to-Highlight-Pre-Clinical-and-Clinical-Activities-at-ORS-and-AAOS-Meetings-752425</guid></item><item><title>BioMimetic Therapeutics Completes Submission of PMA Application for FDA Approval of Augment™ Bone Graft</title><link>http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Completes-Submission-of-PMA-Application-for-FDA-Approval-of-Augment-Bone-Graft-744173</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
.bwunderlinestyle {text-decoration: underline}
--&gt;
&lt;/style&gt;

			&lt;!-- sh_cad_1 --&gt;
      BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced it has 
      submitted the  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Completes-Submission-of-PMA-Application-for-FDA-Approval-of-Augment-Bone-Graft-744173</guid></item><item><title>BioMimetic Therapeutics, Inc. Patent Portfolio Further Strengthened</title><link>http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Inc-Patent-Portfolio-Further-Strengthened-735703</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
.bwunderlinestyle {text-decoration: underline}
--&gt;
&lt;/style&gt;

			&lt;!-- sh_cad_1 --&gt;
      BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today the 
      European Patent Office  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Inc-Patent-Portfolio-Further-Strengthened-735703</guid></item><item><title>BioMimetic Therapeutics Ships Augment™ Bone Graft to Canadian Distributor</title><link>http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Ships-Augment-Bone-Graft-to-Canadian-Distributor-714885</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
.bwunderlinestyle {text-decoration: underline}
--&gt;
&lt;/style&gt;

			&lt;!-- sh_cad_1 --&gt;
      BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that the 
      Company has  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Ships-Augment-Bone-Graft-to-Canadian-Distributor-714885</guid></item><item><title>Novo A/S Implements 10b5-1 Trading Plan for Purchase of Additional BioMimetic Therapeutics Shares</title><link>http://www.finanzen.net/nachricht/Novo-A-S-Implements-10b5-1-Trading-Plan-for-Purchase-of-Additional-BioMimetic-Therapeutics-Shares-713251</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
.bwunderlinestyle {text-decoration: underline}
--&gt;
&lt;/style&gt;

			&lt;!-- sh_cad_1 --&gt;
      BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) and Novo A/S announced that 
      on December  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Novo-A-S-Implements-10b5-1-Trading-Plan-for-Purchase-of-Additional-BioMimetic-Therapeutics-Shares-713251</guid></item><item><title>BioMimetic Therapeutics, Inc. to Present at the Piper Jaffray 21st Annual Healthcare Conference</title><link>http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Inc-to-Present-at-the-Piper-Jaffray-21st-Annual-Healthcare-Conference-709158</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
.bwunderlinestyle {text-decoration: underline}
--&gt;
&lt;/style&gt;

			&lt;!-- sh_cad_1 --&gt;
      BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Steven 
      Hirsch, COO  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Inc-to-Present-at-the-Piper-Jaffray-21st-Annual-Healthcare-Conference-709158</guid></item><item><title>BioMimetic Therapeutics Reports 2009 Third Quarter Earnings Results</title><link>http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Reports-2009-Third-Quarter-Earnings-Results-697118</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwcellpaddingbottom1 {padding-bottom: 2.0px}
.bwcellpaddingbottom3 {padding-bottom: 4.0px}
.bwcellpaddingleft0 {padding-left: 0.0px}
.bwcellpaddingleft2 {padding-left: 10.0px}
.bwcellpaddingleft4 {padding-left: 20.0px}
.bwcellpaddingright0  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/BioMimetic-Therapeutics-Reports-2009-Third-Quarter-Earnings-Results-697118</guid></item></channel></rss>

